1887

Abstract

There are limited data on human papillomavirus (HPV) type-specific cervical cancer risk among human immunodeficiency virus (HIV)-positive women. Previous studies have suggested that HPV 16 would be relatively less important as a causative agent among HIV-positive compared with HIV-negative women. This study investigates HPV type-specific cervical cancer risk in a population in which HIV is endemic. At the Central Hospital, Maputo, Mozambique, 221 cervical cancer cases and 203 hospital-based controls were consecutively enrolled. HPV typing from cervical samples, HIV testing and recording of socio-demographic factors were performed. Logistic regression modelling was used to assess HPV type-specific risk and effect modification between HIV and HPV infection. Infection with HPV 16, 18 and ‘high-risk non-HPV 16/18 types’ (HPV 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59) was associated with cervical cancer in both crude and adjusted analyses. HPV 16 and 18 were the most common types detected in cancer biopsies among both HIV-negative and HIV-positive women. There was no significant evidence of effect modification between any HPV type and HIV infection, and there were no significant differences in the HPV type-specific prevalence when cervical cancers among HIV-positive and HIV-negative women were compared. Within the limitations of the study, the relative importance of different HPV types in cervical carcinogenesis appears not to be modified greatly by HIV infection, suggesting that HPV vaccines might not need to be type-specifically modified to be suitable for populations where HIV is endemic.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.034298-0
2011-12-01
2019-12-08
Loading full text...

Full text loading...

/deliver/fulltext/jgv/92/12/2784.html?itemId=/content/journal/jgv/10.1099/vir.0.034298-0&mimeType=html&fmt=ahah

References

  1. Ahdieh L., Klein R. S., Burk R., Cu-Uvin S., Schuman P., Duerr A., Safaeian M., Astemborski J., Daniel R., Shah K.. ( 2001; ). Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. . J Infect Dis 184:, 682–690. [CrossRef] [PubMed]
    [Google Scholar]
  2. Castellsagué X., Klaustermeier J., Carrilho C., Albero G., Sacarlal J., Quint W., Kleter B., Lloveras B., Ismail M. R. et al. & other authors ( 2008; ). Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for prevention. . Int J Cancer 122:, 1901–1904. [CrossRef] [PubMed]
    [Google Scholar]
  3. CDC ( 1992; ). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. . MMWR Recomm Rep 41:, 1–19.
    [Google Scholar]
  4. Clifford G. M., Gonçalves M. A., Franceschi S..HPV and HIV Study Group ( 2006; ). Human papillomavirus types among women infected with HIV: a meta-analysis. . AIDS 20:, 2337–2344. [CrossRef] [PubMed]
    [Google Scholar]
  5. Cogliano V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F..WHO International Agency for Research on Cancer ( 2005; ). Carcinogenicity of human papillomaviruses. . Lancet Oncol 6:, 204. [CrossRef] [PubMed]
    [Google Scholar]
  6. de Sanjose S., Quint W. G., Alemany L., Geraets D. T., Klaustermeier J. E., Lloveras B., Tous S., Felix A., Bravo L. E. et al. & other authors ( 2010; ). Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. . Lancet Oncol 11:, 1048–1056. [CrossRef] [PubMed]
    [Google Scholar]
  7. De Vuyst H., Gichangi P., Estambale B., Njuguna E., Franceschi S., Temmerman M.. ( 2008; ). Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya. . Int J Cancer 122:, 244–246. [CrossRef] [PubMed]
    [Google Scholar]
  8. Eklund C., Zhou T., Dillner J..WHO Human Papillomavirus Laboratory Network ( 2010; ). Global proficiency study of human papillomavirus genotyping. . J Clin Microbiol 48:, 4147–4155. [CrossRef] [PubMed]
    [Google Scholar]
  9. Kleter B., van Doorn L. J., Schrauwen L., Molijn A., Sastrowijoto S., ter Schegget J., Lindeman J., ter Harmsel B., Burger M., Quint W.. ( 1999; ). Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. . J Clin Microbiol 37:, 2508–2517.[PubMed]
    [Google Scholar]
  10. Li N., Franceschi S., Howell-Jones R., Snijders P. J., Clifford G. M.. ( 2011; ). Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. . Int J Cancer 128:, 927–935. [CrossRef] [PubMed]
    [Google Scholar]
  11. Moscicki A. B., Ellenberg J. H., Farhat S., Xu J.. ( 2004; ). Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type. . J Infect Dis 190:, 37–45. [CrossRef] [PubMed]
    [Google Scholar]
  12. Muñoz N., Bosch F. X., Castellsagué X., Díaz M., de Sanjose S., Hammouda D., Shah K. V., Meijer C. J.. ( 2004; ). Against which human papillomavirus types shall we vaccinate and screen? The international perspective. . Int J Cancer 111:, 278–285. [CrossRef] [PubMed]
    [Google Scholar]
  13. Naucler P., Ryd W., Törnberg S., Strand A., Wadell G., Hansson B. G., Rylander E., Dillner J.. ( 2007; ). HPV type-specific risks of high-grade CIN during 4 years of follow-up: a population-based prospective study. . Br J Cancer 97:, 129–132. [CrossRef] [PubMed]
    [Google Scholar]
  14. Parkin D. M., Bray F., Ferlay J., Pisani P.. ( 2005; ). Global cancer statistics, 2002. . CA Cancer J Clin 55:, 74–108. [CrossRef] [PubMed]
    [Google Scholar]
  15. Quint W. G., Scholte G., van Doorn L. J., Kleter B., Smits P. H., Lindeman J.. ( 2001; ). Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF10 PCR and HPV genotyping. . J Pathol 194:, 51–58. [CrossRef] [PubMed]
    [Google Scholar]
  16. Rothman K. J., Greenland S.. ( 1998; ). Modern Epidemiology. Philadelphia, PA:: Lippincott–Raven;.
    [Google Scholar]
  17. Schiffman M., Clifford G., Buonaguro F. M.. ( 2009; ). Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. . Infect Agent Cancer 4:, 8. [CrossRef] [PubMed]
    [Google Scholar]
  18. Schmitt M., Bravo I. G., Snijders P. J., Gissmann L., Pawlita M., Waterboer T.. ( 2006; ). Bead-based multiplex genotyping of human papillomaviruses. . J Clin Microbiol 44:, 504–512. [CrossRef] [PubMed]
    [Google Scholar]
  19. Smith J. S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., Clifford G. M.. ( 2007; ). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. . Int J Cancer 121:, 621–632. [CrossRef] [PubMed]
    [Google Scholar]
  20. Söderlund-Strand A., Carlson J., Dillner J.. ( 2009; ). Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus. . J Clin Microbiol 47:, 541–546. [CrossRef] [PubMed]
    [Google Scholar]
  21. Söderlund-Strand A., Eklund C., Kemetli L., Grillner L., Törnberg S., Dillner J., Dillner L.. ( 2011; ). Genotyping of human papillomavirus in triaging of low-grade cervical cytology. . Am J Obstet Gynecol 205:, 145.e1. [CrossRef] [PubMed]
    [Google Scholar]
  22. Strickler H. D., Palefsky J. M., Shah K. V., Anastos K., Klein R. S., Minkoff H., Duerr A., Massad L. S., Celentano D. D. et al. & other authors ( 2003; ). Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. . J Natl Cancer Inst 95:, 1062–1071. [CrossRef] [PubMed]
    [Google Scholar]
  23. Strickler H. D., Palefsky J. M., Burk R. D.. ( 2008; ). HPV types present in invasive cervical cancers of HIV-seropositive women. . Int J Cancer 123:, 1224–1225. [CrossRef] [PubMed]
    [Google Scholar]
  24. Sun X. W., Kuhn L., Ellerbrock T. V., Chiasson M. A., Bush T. J., Wright T. C. Jr. ( 1997; ). Human papillomavirus infection in women infected with the human immunodeficiency virus. . N Engl J Med 337:, 1343–1349. [CrossRef] [PubMed]
    [Google Scholar]
  25. Walboomers J. M. M., Jacobs M. V., Manos M. M., Bosch F. X., Kummer J. A., Shah K. V., Snijders P. J. F., Peto J., Meijer C. J. L. M., Muñoz N.. ( 1999; ). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. . J Pathol 189:, 12–19. [CrossRef] [PubMed]
    [Google Scholar]
  26. Wallin K. L., Wiklund F., Angström T., Bergman F., Stendahl U., Wadell G., Hallmans G., Dillner J.. ( 1999; ). Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. . N Engl J Med 341:, 1633–1638. [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.034298-0
Loading
/content/journal/jgv/10.1099/vir.0.034298-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error